跳至主要内容
临床试验/NCT01946932
NCT01946932已完成不适用

Cognitive Impairment Following Cardiac Arrest and Target Temperature Management

Region Skane20 个研究点 分布在 5 个国家目标入组 287 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Region Skane
入组人数
287
试验地点
20
主要终点
Rivermead Behavioural Memory Test (RBMT)

研究概览

简要总结

This is a steering group approved substudy to the Target Temperature Management trial (TTM, ClinicalTrials.gov Identifier: NCT01020916). TTM compares the effect of two strictly controlled temperature regimes for survivors of out-of-hospital cardiac arrest.

The primary aim of this sub-study is to compare the amount of cognitive impairment in cardiac arrest survivors treated with 33 degrees and 36 degrees and with a matched group of control patients with myocardial infarction.

Our secondary aims are:

  • To investigate the impact of cognitive impairment on our patients' ability to participate in society and their health related quality of life.
  • To investigate the relationship between our patients cognitive impairments and their relatives/informants health related quality of life and feelings of burden.
  • To test the hypothesis that the simple cognitive screening battery used in the TTM main trial is sensitive enough to detect all patients with significant cognitive disability.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Out-of-Hospital Cardiac Arrest (OHCA)of presumed cardiac cause
  • Unconsciousness after sustained return of spontaneous circulation (ROSC)
  • Exclusion Criteria at time for inclusion in the TTM study:
  • Known bleeding diathesis
  • Suspected or confirmed acute intracranial bleeding
  • Suspected or confirmed stroke
  • Unwitnessed asystole
  • Known limitations in therapy and Do Not Resuscitate-order
  • Known disease making 180 days survival unlikely
  • Known prearrest status Cerebral Performance Category (CPC)3 or 4
  • Temperature <30°on admission
  • 4 hours (240 minutes) from ROSC to screening
  • Systolic blood pressure <80 mm Hg in spite of fluid loading/vasopressor and/or inotropic medication/intra aortic balloon pump
  • In-hospital cardiac arrest
  • OHCA of presumed non-cardiac arrest cause
  • Additional Exclusion criteria for the sub-study:
  • Disability to speak the site language well enough to complete tests without interpreter
  • Controls should never have suffered a cardiac arrest

排除标准

  • 未提供

结局指标

主要结局

Rivermead Behavioural Memory Test (RBMT)

时间窗: 180 days after Cardiac Arrest (CA) or Myocardial Infarction (MI)

Memory test

Frontal Assessment Battery (FAB)

时间窗: 180 days after CA or MI

Screening of Executive functions

Symbol Digit Modalities Test (SDMT)

时间窗: 180 days after CA or MI

Assess attention, mental speed and concentration

次要结局

  • Mayo-Portland Adaptability Inventory-4 (MPAI-4)(180 days after CA or MI)
  • Short-Form Questionnaire 36 version 2 (SF-36v2)(180 days after CA or MI)
  • Zarit Burden Interview(180 days after CA or MI)
  • Hospital Anxiety and Depression rating Scale (HADS)(180 days after CA or MI)
  • Two Simple Questions (TSQ)(180 days after CA or MI)
  • Informant Questionnaire on Cognitive Decline (IQCODE)(180 days after CA or MI)
  • MiniMental Status Examination (MMSE)(180 days after CA or MI)
  • Cerebral Performance Category (CPC)(180 days after CA or MI)
  • modified Rankin Scale(180 days after CA or MI)

研究者

发起方
Region Skane
申办方类型
Other
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验